Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. Vigil Neuroscience's Goodwill for the quarter that ended in Dec. 2024 was $0.00 Mil. Vigil Neuroscience's Total Assets for the quarter that ended in Dec. 2024 was $117.69 Mil.
Vigil Neuroscience Goodwill-to-Asset Historical Data
The historical data trend for Vigil Neuroscience's Goodwill-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vigil Neuroscience's Goodwill-to-Asset
For the Biotechnology subindustry, Vigil Neuroscience's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vigil Neuroscience's Goodwill-to-Asset Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vigil Neuroscience's Goodwill-to-Asset distribution charts can be found below:
* The bar in red indicates where Vigil Neuroscience's Goodwill-to-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.
Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.
Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.
Vigil Neuroscience Goodwill-to-Asset Related Terms
Thank you for viewing the detailed overview of Vigil Neuroscience's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VIGL has been successfully added to your 